Impact of Exogenous Estrogens on Cotisol Levels During Synacthen Stimulation
NCT ID: NCT05302726
Last Updated: 2022-03-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2022-01-01
2023-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version
NCT07092527
Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure
NCT00998933
Pubertal Induction in Individuals With Hypogonadism
NCT02871986
Extragonadal Effects of hCG on Calcium Homeostasis
NCT03418896
Testosterone Gel Applied to Women With Pituitary Gland Problems
NCT00144391
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oral estrogen
oral estrogen (2 mg/24 hours)
Estrogen
Transdermal and oral estrogen both as substitution therapy
Transdermal estrogen
Transdermal estrogen (100ug/24 hours)
Estrogen
Transdermal and oral estrogen both as substitution therapy
No treatment
Estrogen pause
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Estrogen
Transdermal and oral estrogen both as substitution therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Treatment with estrogen substitution
Exclusion Criteria
* Pregnancy
* BMI \> 35
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mikkel Andreassen
Consultant, PhD associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mikkel M Andreassen
Role: PRINCIPAL_INVESTIGATOR
Department of endocrinology and metabolism
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mikkel Mr Andreassen
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-20048992
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.